On-demand webinar

ZEISS Educational Webinar

Spotlight on ZEISS IOLs: Evidence-based Insights from ESCRS 2025 on AT ELANA 841P

11 December 2025

Moderator Professor Gerd Auffarth, FEBO Professor and Chairman of the Department of Ophthalmology at the Ruprecht-Karls-University Heidelberg, Germany

Director of the David J. Apple International Laboratory for Ocular Pathology, and Director of the International Vision Correction Research Centre (IVCRC).

Speaker Andrea Janeková, MD, FEBO, FEBOS-CR Head of Cataract, Refractive & Vitreoretinal Surgery, Eye Center Prague, Czech Republic

Speaker PD Timur Yildirim, MD, MHBA, FEBO Senior Cataract and Refractive Surgeon at the Department of Ophthalmology at the Ruprecht-Karls-University Heidelberg, Germany

SUMMARY

Spotlight on ZEISS IOLs:
Evidence-based Insights from ESCRS 2025 on AT ELANA 841P

This second episode of the three-part webinar series presents clinical findings from Andrea Janeková and Timur Yildirim, focusing on the performance and patient satisfaction related to the ZEISS AT ELANA 841P.

Key findings from Andrea Janeková's presentation:

Close to 90% of eyes achieve better than 0.1 logMAR for uncorrected distance vision.
85% of eyes were within 0.5 diopters of spherical equivalent, with stability observed across all postoperative study visits from week 1 to month 6.
AT ELANA 841P provides a continuous range of vision, with no drop-offs in intermediate distances as illustrated by the binocular defocus curve
The lens performs well within reference ranges for contrast sensitivity under photopic and mesopic conditions

Key highlights from Timur Yildirim's presentation:

91% of patients reported satisfaction with overall vision within three months post-surgery, surpassing previous studies using the AIOLIS questionnaire.
Spectacle independence was high, with 88% of patients seeing well without glasses.
Less than 10% reported bothersome photopic phenomena like halos and glare, indicating good patient adaptation to the lens.
AT ELANA 841P offers continuous vision across all distances, with high patient satisfaction and spectacle independence, performing slightly better than previous studies using the AIOLIS instrument.

Overall, the presentations underscore the effectiveness and patient satisfaction associated with the AT ELANA 841P, highlighting its stability, full range of vision, and minimal photopic disturbances.